Healthspan Economy

ClinicalTrials.gov · NCT05294835 · Unknown status

Ketamine and Epigenetic Aging

Registry record

NCT05294835 on ClinicalTrials.gov. The registry's last update to this record was 8 September 2022.

Date checked: . This is the day the Atlas read the registry record; the registry may have changed since.

Verification record

5 checked · 0 company says · 0 reported · 0 not found · 0 not yet checked

  • Title as registered Ketamine and Epigenetic Aging Checked Source clinicaltrials.gov Brief title as registered. Checked
  • Sponsor TruDiagnostic Checked Source clinicaltrials.gov Lead sponsor as registered. Checked
  • Intervention Ketamine Checked Source clinicaltrials.gov Intervention names as registered. Checked
  • Primary outcome as registered Epigenetic Age Checked Source clinicaltrials.gov Primary outcome measure(s) as registered. Checked
  • Status Unknown status Checked Source clinicaltrials.gov Overall status as registered; registry last update 2022-09-08. Checked

Check history: NCT05294835 was last read on the registry on November 14, 2026. No earlier checks are recorded. How records are checked.

Corrections: none recorded for this trial. To ask for one, write to [email protected] with the registry number; every correction is checked against the registry record before the record changes.

As registered

  • Sponsor: TruDiagnostic
  • Phase: Phase 2
  • Status: Unknown status
  • Intervention: Ketamine
  • Primary outcome: Epigenetic Age
  • Countries: United States
  • Start: 1 April 2022
  • Completion (estimated): 31 December 2022

Results

No results were posted on the registry on the date checked. The Atlas does not summarize findings.

A trial being registered is not evidence that the intervention works.